Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome

Lupus

Volumn 13, Issue 3, 2004, Pages 177-181

  Simón, J Abraham ^a   Rojas Serrano, J ^a   Cabiedes, J ^a   Alcocer Varela, J ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antinucleosome antibodies; Primary antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY DISEASE; MALE; NEUROLOGIC DISEASE; PHOTOSENSITIVITY; PREDICTION; PRIORITY JOURNAL; RASH; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

EID: 1842731982     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu526oa     Document Type: Article

References (19)

1. Hughes G. The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 25: 285-286.
2. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
3. Asherson R, Baguley E, Pal C, Hughes G. Antiphospholipid syndrome: 5 years follow-up. Ann Rheum Dis 1991; 50: 805-810.
4. Silver R, Draper M, Scott J, Lyon J, Reading J, Branch D. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83: 372-377.
5. Piette JC, Wechsler B, Frances C, Godeau P. Systemic lupus erythematosus and antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol 1992; 19: 1835-1837.
6. Asherson R. SLE and the antiphospholipid antibody syndrome. J Rheumatol 1993; 20: 1801-1802.
7. Berman L. Primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1802.
8. Piette JC. Primary antiphospholipid syndrome (PAPS) or systemic lupus erythematosus related APS: from theory to practice. J Rheumatol 1994; 21: 1368-1369.
9. Cabral A, Alarcón-Segovia D. Will some day PAPS fade into SLE? Lupus 1996; 5: 4-5.
10. Mujic F, Cuadrado M, Lloyd M, Khamashta M, Page G, Hughes G. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589-1592.
11. Derksen R, Gmeling-Meijling F, Groot P. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1996; 5: 77-80.
12. Seisedos L, Muñoz-Rodriguez J, Cervera R, Font J, Ingelmo M. Primary antiphospholipid syndrome evolving into systemic lupus erthyematosus. Lupus 1997; 6: 285-286.
13. Piette JC, Wechsler B, Frances C, Papo T, Godeau P. Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1802-1803.
14. Blanco Y, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Igelmo M. Síndrome antifosfolípido primario que evoluciona a lupus eritematoso sistémico: presentación de tres nuevos casos y revision de la literature. Rev Clin Esp 1999; 199: 586-588.
15. Amoura Z, Chabre H, Koutouzov S et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 1684-1688.
16. Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 2004; 43: 220-224.
17. Alarcón-Segovia D, Pérez-Vazquez M, Villa A, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275-286.
18. Tan E, Cojen A, Fries J et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Arbuckle M, James J, Kohlhase K, Rubertone M, Dennis G, Harley J. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001; 54: 211-219.